Catherine Moukheibir - Jun 6, 2024 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role: Director
Signature: /s/ Brian Tessler, Attorney-in-Fact
Stock symbol: IRWD
Transactions as of: Jun 6, 2024
Transactions value $: -$517,694
Form type: 4
Date filed: 6/10/2024, 04:58 PM
Previous filing: Dec 19, 2023
Next filing: Jun 21, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRWD	Class A Common Stock	Sale	-$283K	-44.4K	-34.54%	$6.36	84.2K	Jun 6, 2024	Direct	F1
transaction	IRWD	Class A Common Stock	Sale	-$235K	-35.6K	-42.25%	$6.61	48.6K	Jun 7, 2024	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.30 to $6.43, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.56 to $6.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.30 to $6.43, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.56 to $6.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.